Rb (IF8) AC Antibody sc-102 AC from Santa Cruz Biotechnology, Inc.

Product Specs
ItemRb (IF8) AC Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $416.00Supplier Page View Company Product Page
Catalog Numbersc-102 AC
Antibody TypePrimary Antibody Conjugates
Clonalitymonoclonal
Reactivitymouse, rat, human
FormatPurified
ApplicationsIP
CloneIF8
IsotypeIgG1
Hostmouse
Quantity500 µg/ml, 25% ag
TargetRb
NCBI Full Gene NameRB transcriptional corepressor 1
NCBI Gene AliasesRB, Rb-1, PPP1R130, pRb, pp110, p110-RB1, Rb, pp105, p105-Rb, OSRC
Conjugate/Tagagarose

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) A Potential Anti-Glioblastoma Compound LH20 Induces Apoptosis and Arrest of Human Glioblastoma Cells via CDK4/6 InhibitionMolecules (Basel, Switzerland)June 28, 2023Wang Y, Li Y, Liu D, Zheng D, Li X, Li C, Huang C, Wang Y, Wang X, Li Q, et al.

(2) Pak1 pathway hyper-activation mediates resistance to endocrine therapy and CDK4/6 inhibitors in ER+ breast cancerNPJ breast cancerMay 31, 2023Belli S, Esposito D, Allotta A, Servetto A, Ciciola P, Pesapane A, Ascione CM, Napolitano F, Di Mauro C, Vigliar E, et al.

(3) CCNE1 and PLK1 Mediate Resistance to Palbociclib in HR+/HER2- Metastatic Breast CancerClinical cancer research : an official journal of the American Association for Cancer ResearchApril 14, 2023Guerrero-Zotano Á, Belli S, Zielinski C, Gil-Gil M, Fernandez-Serra A, Ruiz-Borrego M, Ciruelos Gil EM, Pascual J, Muñoz-Mateu M, Bermejo B, et al.

(4) Antioxidants prevent particulate matter-induced senescence of lung fibroblastsHeliyonMarch 1, 2023Jin S, Yoon SJ, Jung NY, Lee WS, Jeong J, Park YJ, Kim W, Oh DB, Seo J.

(5) Combined inhibition of ACLY and CDK4/6 reduces cancer cell growth and invasionOncology reportsFebruary 1, 2023Velez BC, Petrella CP, DiSalvo KH, Cheng K, Kravtsov R, Krasniqi D, Krucher NA.

(6) KNTC1, regulated by HPV E7, inhibits cervical carcinogenesis partially through Smad2Experimental cell researchFebruary 1, 2023Pan W, Wang S, Liu X, Wang M, Han X, Tian X, Lin J, Qiao X, Wang X.

(7) Plakophilin 3 facilitates G1/S phase transition and enhances proliferation by capturing RB protein in the cytoplasm and promoting EGFR signalingCell reportsJanuary 31, 2023Müller L, Keil R, Hatzfeld M.

(8) Human Papillomavirus 42 Drives Digital Papillary Adenocarcinoma and Elicits a Germ Cell-like Program Conserved in HPV-Positive CancersCancer discoveryJanuary 9, 2023Leiendecker L, Neumann T, Jung PS, Cronin SM, Steinacker TL, Schleiffer A, Schutzbier M, Mechtler K, Kervarrec T, Laurent E, et al.

(9) Cell division cycle associated 8 promotes the growth and inhibits the apoptosis of endometrial cancer cells by regulating cell cycle and P53/Rb signaling pathwayAmerican journal of translational researchJanuary 1, 2023Li W, Qin Y, Chen X, Wang X.

(10) Downregulation of natriuretic peptide receptor-C in vascular smooth muscle cells from spontaneously hypertensive rats contributes to vascular remodelingPeptidesDecember 1, 2022Li Y, Anand-Srivastava MB.

(11) Pro-Apoptotic and Anti-Invasive Properties Underscore the Tumor-Suppressing Impact of Myoglobin on a Subset of Human Breast Cancer CellsInternational journal of molecular sciencesSeptember 29, 2022Aboouf MA, Armbruster J, Thiersch M, Guscetti F, Kristiansen G, Schraml P, Bicker A, Petry R, Hankeln T, Gassmann M, et al.

(12) Potential anti-skin aging effect of a peptide AYAPE isolated from Isochrysis zhanjiangensis on UVB-induced HaCaT cells and H(2)O(2)-induced BJ cellsJournal of photochemistry and photobiology. B, BiologyAugust 1, 2022He YL, Lin L, Zheng H, Mo Y, Zhou C, Sun S, Hong P, Qian ZJ.

(13) Phosphorylation of mixed lineage kinase MLK3 by cyclin-dependent kinases CDK1 and CDK2 controls ovarian cancer cell divisionThe Journal of biological chemistryAugust 1, 2022Cedeno-Rosario L, Honda D, Sunderland AM, Lewandowski MD, Taylor WR, Chadee DN.

(14) Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroupScientific reportsJuly 20, 2022Martinez-Monleon A, Kryh Öberg H, Gaarder J, Berbegall AP, Javanmardi N, Djos A, Ussowicz M, Taschner-Mandl S, Ambros IM, Øra I, et al.

(15) Second Generation Small Molecule Inhibitors of Gankyrin for the Treatment of Pediatric Liver CancerCancersJune 22, 2022D'Souza AM, Gnanamony M, Thomas M, Hanley P, Kanabar D, de Alarcon P, Muth A, Timchenko N.

(16) E6/E7 from Beta-2-HPVs 122, 38b, and 107 possess transforming properties in a fibroblast model in vitroExperimental cell researchMay 15, 2022Castro-Amaya AM, Fernández-Avila L, Barrón-Gallardo CA, Moreno-Rios CE, Guevara-Hernández SN, Magaña-Torres MT, Pelayo-Aguirre CJ, Jave-Suárez LF, Aguilar-Lemarroy A.

(17) Age-associated decline of MondoA drives cellular senescence through impaired autophagy and mitochondrial homeostasisCell reportsMarch 1, 2022Yamamoto-Imoto H, Minami S, Shioda T, Yamashita Y, Sakai S, Maeda S, Yamamoto T, Oki S, Takashima M, Yamamuro T, et al.

(18) A Point Mutation R122C in RUNX3 Promotes the Expansion of Isthmus Stem Cells and Inhibits Their Differentiation in the StomachCellular and molecular gastroenterology and hepatologyJanuary 1, 2022Douchi D, Yamamura A, Matsuo J, Lee JW, Nuttonmanit N, Melissa Lim YH, Suda K, Shimura M, Chen S, Pang S, et al.

(19) Ciclopirox Olamine Exerts Tumor-Suppressor Effects via Topoisomerase II Alpha in Lung AdenocarcinomaFrontiers in oncologyJanuary 1, 2022Yin J, Che G, Jiang K, Zhou Z, Wu L, Xu M, Liu J, Yan S.

(20) The SREBP-dependent regulation of cyclin D1 coordinates cell proliferation and lipid synthesisFrontiers in oncologyJanuary 1, 2022Aldaalis A, Bengoechea-Alonso MT, Ericsson J.

Be the First to Write a Review!

Rb (IF8) AC Antibody

Rb (IF8) AC Antibody from Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc.

Citations (366)

Reviews

Rb (IF8) AC Antibody from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map